Digest Network Come funziona
Network
/
Società
Ep
Non verificato

Epicrispr Biotechnologies

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

16 comunicati stampa

Guarda tutti i comunicati
20/10/2026
Multimedialità
Biotecnologia
Salute
Farmaceutica
Mercato del lavoro
Epicrispr Biotechnologies Appoints Enoch Kariuki, PharmD, to Board of Directors
Fonte
Epicrispr Biotechnologies
Emittente
Business Wire
1.00
0
19/10/2026
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Industria
Epicrispr Biotechnologies Awarded $8 Million CIRM Grant to Advance EPI-321 for FSHD
Fonte
Epicrispr Biotechnologies
Emittente
Business Wire
1.00
0
05/10/2026
Fiere
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Epicrispr Reports Positive Six-Month Data at The World Muscle Society Meeting Demonstrating Increased Lean Muscle Volume and Muscle Strength in FSHD Patients Treated with EPI-321
Fonte
Epicrispr Biotechnologies
Emittente
Business Wire
1.00
0
11/08/2026
Industria
Igiene alimentare
Sanità
Finanza
Farmaceutica
Associazioni/Professionisti
Biotecnologia
Infanzia
Medicina - Varie
Famiglia
Scienza
Vetrine/Shopping
Salute
Epicrispr Biotechnologies Closes $90 Million Oversubscribed Series C Financing to Advance First-in-Class Epigenetic Therapy Toward Pivotal Studies in FSHD
Fonte
Epicrispr Biotechnologies
Emittente
Business Wire
1.00
0
07/07/2026
Eventi
Industria
Scienza
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Epicrispr Completes Enrollment and Dose Escalation in First-in-Human EPI-321 Trial for FSHD
Fonte
Epicrispr Biotechnologies
Emittente
Business Wire
1.00
0
27/06/2026
Epicrispr Reports First Clinical Evidence of Increased Lean Muscle Volume in Patients with FSHD Following Treatment with EPI-321
Fonte
Epicrispr Biotechnologies
Emittente
Business Wire
1.00
0
26/06/2026
Epicrispr Reports First Clinical Evidence of Increased Lean Muscle Volume in Patients with FSHD Following Treatment with EPI-321
Fonte
Epicrispr Biotechnologies
Emittente
Business Wire
1.00
0
24/03/2026
Epicrispr Biotechnologies Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
Fonte
Epicrispr Biotechnologies
Emittente
Business Wire
1.00
0
08/01/2026
Eventi
Industria
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Epicrispr Reports Early Clinical Activity and Favorable Safety Profile in First-in-Human Epigenetic Editing Study for FSHD
Fonte
Epicrispr Biotechnologies
Emittente
Business Wire
1.00
0
08/12/2025
Eventi
Web e Social Network
Associazioni/Professionisti
Salute
Finanza
Medicina - Varie
Farmaceutica
Biotecnologia
Epicrispr Biotechnologies to Present at 44th Annual J.P. Morgan Healthcare Conference
Fonte
Epicrispr Biotechnologies
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0